Searched for
NOVARTIS AG
Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...- Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...
- Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- Novartis puts its India-listed entity for up for saleThe strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assu...
- Novartis India denies delisting plans; stock plunges over 13%The stock had ended 15.72 per cent in previous trade following media reports that “Novartis AG was planning to delist Indian units.
- Novartis India Q4 net up 2 folds at Rs 51.94 crorePharmaceuticals firm Novartis India today reported over two-fold increase in standalone net at Rs 51.94 crore for the fourth quarter ended ...
- Ready to pay "reasonable" royalty to Novartis AG: Cipla to HCCipla was making submission for lifting the stay ordered by a single judge bench restraining it from manufacturing the drug.
- Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-croreNovartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...
- Novartis AG sells 1.42% stake in Indian arm for Rs 25 croreDrug firm Novartis India today said its parent Novartis AG has offloaded 1.42 per cent stake in it through open market for a consideration ...
- Novartis appoints Citigroup as broker for Indian unit share saleDrug major Novartis India said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share ...
- Novartis India shares up 4% after Swiss-promoter says to cut stakeShares of Novartis India today closed higher by 3.75 per cent, adding Rs 68 crore to its market capitalisation, after its Swiss-promoter sa...
- Novartis AG to reduce promoters stake in Novartis IndiaAs per the shareholding pattern of the company, as on September 30, 2012 Novartis AG had 76.42 stake in Novartis India.
- Novartis gets US approval for meningitis vaccineNovartis AG said that its meningitis vaccine Menveo has been approved for use in teenagers and adults by the US Food and Drug Administratio...
- Novartis raises stake in Indian arm to 76.42 pcSwiss drug maker Novartis AG has hiked its stake to 76.42 per cent in its Indian subsidiary Novartis India pursuant to the completion of op...
- FIs respond to Novartis’ open offerInstitutional shareholders have participated in a big way in Novartis AG’s open offer for its Indian subsidiary Novartis India, boosting th...
- Novartis hikes offer price for arm to Rs 450Novartis AG, the Swiss pharma giant, has increased the open offer price for its subsidiary Novartis India to Rs 450 from Rs 351 per share.
- Novartis soars 20 pc as Swiss parent sweetens offer priceSwiss drug firm Novartis AG sweetened its open offer price to Rs 450 a share for acquiring an additional 39 per cent stake in its Indian su...
- Novartis open offer for Indian arm to begin on May 20Swiss Drug maker Novartis AG's open offer for acquiring an additional 39 pr cent stake in its Indian subsidiary will begin on May 20.
- Novartis open offer for Indian arm to begin on May 14Swiss drug maker Novartis AG's open offer for acquiring an additional 39 per cent stake in its Indian subsidiary will begin on May 14.
Load More
